Cover Image

Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial

Increasing evidence suggests the bidirectional interplay between parathyroid hormone and aldosterone as an important mechanism behind the increased risk of cardiovascular damage and bone disease observed in primary hyperparathyroidism. Our primary object is to assess the efficacy of the mineralocort...

Full description

Saved in:
Bibliographic Details
Main Authors: Tomaschitz, Andreas (Author) , Ritz, Eberhard (Author)
Format: Article (Journal)
Language:English
Published: 13 September 2012
In: BMC endocrine disorders
Year: 2012, Volume: 12
ISSN:1472-6823
DOI:10.1186/1472-6823-12-19
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/1472-6823-12-19
Verlag, kostenfrei, Volltext: https://doi.org/10.1186/1472-6823-12-19
Get full text
Author Notes:Andreas Tomaschitz, Astrid Fahrleitner-Pammer, Burkert Pieske, Nicolas Verheyen, Karin Amrein, Eberhard Ritz, Katharina Kienreich, Jörg H. Horina, Albrecht Schmidt, Elisabeth Kraigher-Krainer, Caterina Colantonio, Andreas Meinitzer and Stefan Pilz

MARC

LEADER 00000caa a2200000 c 4500
001 1577522273
003 DE-627
005 20230426230634.0
007 cr uuu---uuuuu
008 180711s2012 xx |||||o 00| ||eng c
024 7 |a 10.1186/1472-6823-12-19  |2 doi 
035 |a (DE-627)1577522273 
035 |a (DE-576)507522273 
035 |a (DE-599)BSZ507522273 
035 |a (OCoLC)1341013399 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Tomaschitz, Andreas  |e VerfasserIn  |0 (DE-588)106940036X  |0 (DE-627)821859072  |0 (DE-576)428670458  |4 aut 
245 1 0 |a Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism  |b a randomized, double-blind, placebo-controlled trial  |c Andreas Tomaschitz, Astrid Fahrleitner-Pammer, Burkert Pieske, Nicolas Verheyen, Karin Amrein, Eberhard Ritz, Katharina Kienreich, Jörg H. Horina, Albrecht Schmidt, Elisabeth Kraigher-Krainer, Caterina Colantonio, Andreas Meinitzer and Stefan Pilz 
264 1 |c 13 September 2012 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 11.07.2018 
520 |a Increasing evidence suggests the bidirectional interplay between parathyroid hormone and aldosterone as an important mechanism behind the increased risk of cardiovascular damage and bone disease observed in primary hyperparathyroidism. Our primary object is to assess the efficacy of the mineralocorticoid receptor-blocker eplerenone to reduce parathyroid hormone secretion in patients with parathyroid hormone excess. 
650 4 |a Aldosterone 
650 4 |a Hyperparathyroidism 
650 4 |a Mineralocorticoid receptor blocker 
700 1 |a Ritz, Eberhard  |d 1938-2023  |e VerfasserIn  |0 (DE-588)106673386  |0 (DE-627)610528866  |0 (DE-576)311552501  |4 aut 
773 0 8 |i Enthalten in  |t BMC endocrine disorders  |d [Erscheinungsort nicht ermittelbar] : BioMed Central, 2001  |g 12(2012) Artikel-Nummer 19, 9 Seiten  |h Online-Ressource  |w (DE-627)355456575  |w (DE-600)2091323-0  |w (DE-576)107015226  |x 1472-6823  |7 nnas  |a Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism a randomized, double-blind, placebo-controlled trial 
773 1 8 |g volume:12  |g year:2012  |g extent:9  |a Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism a randomized, double-blind, placebo-controlled trial 
856 4 0 |u http://dx.doi.org/10.1186/1472-6823-12-19  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://doi.org/10.1186/1472-6823-12-19  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20180711 
993 |a Article 
994 |a 2012 
998 |g 106673386  |a Ritz, Eberhard  |m 106673386:Ritz, Eberhard  |d 910000  |d 910100  |e 910000PR106673386  |e 910100PR106673386  |k 0/910000/  |k 1/910000/910100/  |p 6 
999 |a KXP-PPN1577522273  |e 3017338975 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Andreas Tomaschitz, Astrid Fahrleitner-Pammer, Burkert Pieske, Nicolas Verheyen, Karin Amrein, Eberhard Ritz, Katharina Kienreich, Jörg H. Horina, Albrecht Schmidt, Elisabeth Kraigher-Krainer, Caterina Colantonio, Andreas Meinitzer and Stefan Pilz"]},"id":{"doi":["10.1186/1472-6823-12-19"],"eki":["1577522273"]},"origin":[{"dateIssuedKey":"2012","dateIssuedDisp":"13 September 2012"}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"name":{"displayForm":["BioMed Central"]},"id":{"zdb":["2091323-0"],"eki":["355456575"],"issn":["1472-6823"]},"origin":[{"publisherPlace":"[Erscheinungsort nicht ermittelbar]","dateIssuedDisp":"2001-","dateIssuedKey":"2001","publisher":"BioMed Central"}],"language":["eng"],"corporate":[{"role":"isb","roleDisplay":"Herausgebendes Organ","display":"Biomed Central"}],"recId":"355456575","disp":"Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism a randomized, double-blind, placebo-controlled trialBMC endocrine disorders","type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 22.05.20"],"part":{"year":"2012","volume":"12","text":"12(2012) Artikel-Nummer 19, 9 Seiten","extent":"9"},"pubHistory":["1.2001 -"],"title":[{"title":"BMC endocrine disorders","title_sort":"BMC endocrine disorders"}]}],"physDesc":[{"extent":"9 S."}],"person":[{"display":"Tomaschitz, Andreas","roleDisplay":"VerfasserIn","role":"aut","family":"Tomaschitz","given":"Andreas"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Ritz, Eberhard","given":"Eberhard","family":"Ritz"}],"title":[{"subtitle":"a randomized, double-blind, placebo-controlled trial","title":"Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism","title_sort":"Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism"}],"recId":"1577522273","language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 11.07.2018"]} 
SRT |a TOMASCHITZEFFECTOFEP1320 

Similar Items